Jaundice differential diagnosis: Difference between revisions
No edit summary |
|||
Line 177: | Line 177: | ||
! rowspan="10" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Cholestatic Jaundice | ! rowspan="10" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Cholestatic Jaundice | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Common bile duct stone | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Common bile duct stone | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 190: | Line 190: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |CT/ERCP | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |CT/ERCP | ||
|- | |- | ||
| colspan="1" rowspan="1" |Hepatitis A cholestatic type | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Hepatitis A cholestatic type | ||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
Line 204: | Line 204: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Abdominal ultrasound | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Abdominal ultrasound | ||
|- | |- | ||
| colspan="1" rowspan="1" |EBV / CMV hepatitis | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |EBV / CMV hepatitis | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
Line 218: | Line 218: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
|- | |- | ||
| colspan="1" rowspan="1" |Primary biliary cirrhosis | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Primary biliary cirrhosis | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 247: | Line 247: | ||
Liver biopsy | Liver biopsy | ||
|- | |- | ||
| colspan="1" rowspan="1" |Sickle cell disease | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Sickle cell disease | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 260: | Line 260: | ||
| colspan="2" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Genetic testing | | colspan="2" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Genetic testing | ||
|- | |- | ||
| colspan="1" rowspan="1" |Pancreatic carcinoma | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Pancreatic carcinoma | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 274: | Line 274: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |CT scan for diagnosis | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |CT scan for diagnosis | ||
|- | |- | ||
| colspan="1" rowspan="1" |AIDS cholangiopathy | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |AIDS cholangiopathy | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 288: | Line 288: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Sono or ERCP for diagnosis | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Sono or ERCP for diagnosis | ||
|- | |- | ||
| colspan="1" rowspan="1" |Parasites induces cholestasis | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Parasites induces cholestasis | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 302: | Line 302: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |Sono or ERCP for diagnosis | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |Sono or ERCP for diagnosis | ||
|- | |- | ||
| colspan="1" rowspan="1" |Intrahepatic cholestasis of pregnancy | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Intrahepatic cholestasis of pregnancy | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | -/+ | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 317: | Line 317: | ||
|- | |- | ||
! rowspan="10" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Isolated Jaundice | ! rowspan="10" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Isolated Jaundice | ||
| colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Crigler-Najjar type 2 | |||
| | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
Line 330: | Line 330: | ||
| colspan="2" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Genetic testing | | colspan="2" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Genetic testing | ||
|- | |- | ||
| colspan="1" rowspan="1" | | colspan="1" rowspan="1" style="padding: 5px 5px; background: #DCDCDC;" align="center" |Gilbert | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - |
Revision as of 18:13, 19 December 2017
Jaundice Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Jaundice differential diagnosis On the Web |
American Roentgen Ray Society Images of Jaundice differential diagnosis |
Risk calculators and risk factors for Jaundice differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mehrian Jafarizade, M.D [2]
Overview
Jaundice is yellowish discoloration of the skin, conjunctiva, and mucous membranes caused by hyperbilirubinemia. Usually, the concentration of bilirubin in the blood must exceed 2–3 mg/dL for the coloration to be easily visible. This page contains different causes of jaundice.
Differential diagnosis of jaundice
The differential diagnosis for jaundice, click here.
The differential diagnosis for jaundice and RUQ pain, click here.
The differential diagnosis for jaundice and pruritis, click here.
The differential diagnosis for jaundice and fever, click here.
The differential diagnosis for jaundice, fever, and RUQ pain, click here.
The differential diagnosis for jaundice, pruritis and RUQ pain, click here.
Differential diagnosis of jaundice are: [1][2][3][4]
|
References
- ↑ Fargo MV, Grogan SP, Saguil A (2017). "Evaluation of Jaundice in Adults". Am Fam Physician. 95 (3): 164–168. PMID 28145671.
- ↑ Leevy CB, Koneru B, Klein KM (1997). "Recurrent familial prolonged intrahepatic cholestasis of pregnancy associated with chronic liver disease". Gastroenterology. 113 (3): 966–72. PMID 9287990.
- ↑ Hov JR, Boberg KM, Karlsen TH (2008). "Autoantibodies in primary sclerosing cholangitis". World J. Gastroenterol. 14 (24): 3781–91. PMC 2721433. PMID 18609700.
- ↑ Bond LR, Hatty SR, Horn ME, Dick M, Meire HB, Bellingham AJ (1987). "Gall stones in sickle cell disease in the United Kingdom". Br Med J (Clin Res Ed). 295 (6592): 234–6. PMC 1247079. PMID 3115390.